Table 1.

Differences in postoperative FBG among different clinicopathological parameters.

	No. of patients	Postoperative FBG
		Low	High	P
Age (y)				0.01
<60	62	33	29
≥60	58	18	40
Sex				0.43
Female	40	15	25
Male	80	36	44
Tumor location				0.02
Right	34	20	14
Left	86	31	55
Histological grade				0.07
Well	4	0	4
Moderate	90	36	54
Poor	26	15	11
CEA level				0.13
Normal	82	31	51
Elevated	38	20	18
CA19-9 level				0.08
Normal	102	40	62
Elevated	18	11	7
Invasive depth				0.36
T1+2	26	9	17
T3+4	94	42	52
Maximum tumor diameter (cm)		5.04 ± 2.18	4.14 ± 1.79	0.01
Node involvement				0.01
N0	72	24	48
N1+2	48	27	21
Positive nodes	120	2.94 ± 5.55	1.46 ± 3.24	0.02
TNM stage				0.05
I	21	5	16
II	53	21	32
III	46	25	21
Adjuvant therapies				0.04
Received	70	35	35
None	50	16	34
BMI (kg/m2)	120	22.87 ± 4.18	23.66 ± 3.27	0.33
Preoperative measures
HGB (g/L)	120	119.27 ± 18.95	127.24 ± 12.55	0.01
WBC (×109/L)	120	6.29 ± 1.84	6.45 ± 1.77	0.64
NLR	120	2.66 ± 1.93	2.06 ± 1.20	0.11
MON (×109/L)	120	0.49 ± 0.20	0.50 ± 0.17	0.87
PLT (×109/L)	120	245.35 ± 86.91	250.22 ± 98.50	0.96
ALB (g/L)	120	39.42 ± 5.04	39.86 ± 2.90	0.85